Manufacturing, License and Development Agreements (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Manufacturing, License and Development Agreements (Textual)
Revenues Recognition Milestone Method Milestone			The milestones, totaling $500k (with $405k already received), consist of amounts due upon the first shipment of each identified product, as follows: Phentermine 37.5mg tablets ($145k), Phentermine 15 & 30mg capsules ($45k), Hydromorphone 8mg ($125k), Naltrexone 50mg ($95k) and the balance of $95k due in relation to the first shipment of generic products which still require marketing authorizations from the FDA, and to which there can be no assurances of such marketing authorizations being granted and accordingly there can be no assurances that the Company will earn and receive these milestone amounts.
Revenues	$ 2,693,966	$ 2,535,454	$ 6,224,713	$ 5,861,805
Glenmark Alliance [Member]
Manufacturing, License and Development Agreements (Textual)
Revenues Recognition Milestone Method Milestone			The Glenmark Alliance, provides for the manufacture by Elite and marketing by Glenmark of identified generic products under license from Elite. In addition to the purchase prices for the products, Elite will receive license fees well in excess of 50% of gross profits. Gross profit is defined as net sales less the price paid to Elite for the products, distribution fees (less than 10%) and shipping costs. Glenmark will have semi-exclusive marketing rights to the ANDA approved generic product, phendimetrazine 35mg tablets, and exclusive marketing rights to generic Methadone HCl. Collectively, the brand products and their generic equivalents had total annual sales of approximately $33.6 million in 2017, according to Quintiles IMS Health data. The Agreement has an initial term of three years and automatically renews for one-year periods absent prior written notice of non-renewal. In addition to customary termination provisions, the Agreement permits Glenmark to terminate with regard to a product on at least three months? prior written notice if it determines to stop marketing and selling such product, and it permits Elite to terminate with regard to a product if at any time after the first twelvemonths from the first commercial sale, the average license fee paid by Glenmark for such product is less than $100,000 for a six-month sales period.
License and Service [Member]
Manufacturing, License and Development Agreements (Textual)
Revenues	585,479	451,628	$ 1,767,881	1,700,856
Manufactured Product, Other [Member]
Manufacturing, License and Development Agreements (Textual)
Revenues	$ 2,108,487	$ 2,083,826	4,456,832	$ 4,160,949
License and Maintenance [Member]
Manufacturing, License and Development Agreements (Textual)
Revenues			$ 200,000